Skip to content
value.today

Celladon Corp

🇺🇸 La Jolla, California, USAPharmaceuticalsFounded 2012
Total raised
$49 M
5 rounds on record
Latest round
$3 M
Apr 2016
First round on record
Mar 2008
Today
Private
No later event on record

Funding rounds

5 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Celladon Corp
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2016$3 MNo. 5$2 to $10 million

Celladon Corp: Raise no. 5, Apr 2016

Investors in this round

1 investor had bought by the notice of Apr 29, 2016: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 6 investors are named for Celladon Corp as a whole in other filings: see Investors below.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David A. Cory · Executive Officer, Director
  • Eduardo Bruno Martins · Executive Officer
  • James H. Welch · Executive Officer
  • James P. Shaffer · Executive Officer
  • Joanne H. Quan · Executive Officer
  • Charles J. Bramlage · Director
  • Edgar G. Engleman · Director
  • Jeffrey S. Glenn · Director
  • Nina S. Kjellson · Director
  • Thomas J. Dietz · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by David Cory, President and CEO. Source: SEC Form D, newest notice filed Apr 29, 2016. Read the notice at the SEC.

equitySEC
Oct 2013$1 MNo. 4Under $2 million

Celladon Corp: Raise no. 4, Oct 2013

Investors in this round

17 investors had bought by the notice of Oct 25, 2013: 17 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 6 investors are named for Celladon Corp as a whole in other filings: see Investors below.

What the notice says

Amount sold
$1 M of $2 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Krisztina Zsebo · Executive Officer, Director
  • Rebecque Laba · Executive Officer
  • Andrew E. Senyei · Director
  • Barbara E. Dalton · Director
  • Daniel E. Omstead · Director
  • Fouad E. Azzam · Director
  • Graham E. Cooper · Director
  • Gregg E. Alton · Director
  • Johan E. Kordel · Director
  • Joshua E. Funder · Director
  • Lauren E. Silverman · Director
  • Michael E. Narachi · Director
  • Todd E. Foley · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Total Offering Amount includes amounts receivable by the Issuer upon exercise of certain warrants to purchase the Issuer's Series A-1 Preferred Stock. The warrants have not yet been exercised.”

Signed by Rebecque Laba, VP, Finance & Administration. Source: SEC Form D, newest notice filed Oct 25, 2013. Read the notice at the SEC.

debt, optionsSEC
Jan 2012$19 MNo. 3$10 to $50 million

Celladon Corp: Raise no. 3, Jan 2012

Investors in this round

24 investors had bought by the notice of May 8, 2012: 24 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 6 investors are named for Celladon Corp as a whole in other filings: see Investors below.

What the notice says

Amount sold
$19 M of $65 M offered; $45 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Krisztina Zsebo · Executive Officer, Director
  • Rebecque Laba · Executive Officer
  • Andrew E. Senyei · Director
  • Barbara E. Dalton · Director
  • Daniel E. Omstead · Director
  • Fouad E. Azzam · Director
  • Johan E. Kordel · Director
  • Joshua E. Funder · Director
  • Lauren E. Silverman · Director
  • Todd E. Foley · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Total Offering Amount includes the issuance by Celladon's wholly-owned Netherlands subsidiary of shares that are exchangeable into shares of Celladon. Total Amount Sold includes amounts paid pursuant to conversion of indebtedness.”

Signed by Rebecque Laba, VP, Finance & Administration. Source: SEC Form D and 1 amendment, newest notice filed May 8, 2012. Read the notice at the SEC.

equitySEC
Dec 2009$4 MNo. 2$2 to $10 million

Celladon Corp: Raise no. 2, Dec 2009

Investors in this round

6 investors had bought by the notice of Dec 17, 2009: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 6 investors are named for Celladon Corp as a whole in other filings: see Investors below.

What the notice says

Amount sold
$4 M of $7 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in California

People named in the notice

  • Krisztina Zsebo · Executive Officer, Director
  • Rebecque Laba · Executive Officer
  • Andrew E. Senyei · Director
  • Anthony B. Evnin · Director
  • Asish R. Xavier · Director
  • Kenneth R. Chien · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Issuer may issue Convertible Promissory Notes in an aggregate principal amount of up to $6,500,000 which are convertible into shares of the Issuer's Series C Preferred Stock.”

Signed by Rebecque Laba, VP, Finance & Administration. Source: SEC Form D, newest notice filed Dec 17, 2009. Read the notice at the SEC.

debt, optionsSEC
Mar 2008$22 MNo. 1$10 to $50 million

Celladon Corp: Raise no. 1, Mar 2008

Investors in this round

6 investors had bought by the notice of Sep 10, 2009: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 6 investors are named for Celladon Corp as a whole in other filings: see Investors below.

What the notice says

Amount sold
$22 M of $25 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in California

People named in the notice

  • Krisztina Zsebo · Executive Officer, Director
  • Rebecque Laba · Executive Officer
  • Andrew E. Senyei · Director
  • Anthony B. Evnin · Director
  • Asish Xavier · Director
  • Kenneth R. Chien · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Issuer may issue up to 13,666,668 shares of Series C Preferred Stock at $1.80 per share and warrants to purchase up to 3,111,112 shares of Series C Preferred Stock at an aggregate exercise price of $31,111.12. The warrants have not yet been exercised.”

Signed by Rebecque Laba, VP, Finance & Administration. Source: SEC Form D, newest notice filed Sep 10, 2009. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Celladon Corp had no revenue when it filed its newest notice of a funding round (Apr 2016).

    SEC Form D (revenue range) · Apr 2016

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Apr 2016

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

6 named in official filings. Open an investor to see everything it has backed.

Investors in Celladon Corp
InvestorKindAmountRoundRoleSource
Enterprise Partners Liquidating Trust VFund or asset managernot statednot statedHeld Series A-1 preferred stock, 10% owner (Form 3, 2014)SEC Form 3
Enterprise Partners Liquidating Trust VIFund or asset managernot statednot statedHeld Series A-1 preferred stock, 10% owner (Form 3, 2014)SEC Form 3
Enterprise Partners Management LLCFund or asset managernot statednot statedHeld Series A-1 preferred stock, 10% owner (Form 3, 2014)SEC Form 3
Invest A/s LundbeckfondPersonnot statednot statedHeld Series A-1 preferred stock, 10% owner (Form 3, 2014)SEC Form 3
Novartis Bioventures LtdVenture capitalnot statednot statedHeld Series A-1 preferred stock, 10% owner (Form 3, 2014)SEC Form 3
Pfizer IncFund or asset managernot statednot statedHeld Series A-1 preferred stock, 10% owner (Form 3, 2014)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 24 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Celladon Corp
NameRoleNamed in
David A. CoryExecutive officerApr 2016
Eduardo Bruno MartinsExecutive officerApr 2016
James H. WelchExecutive officerApr 2016
James P. ShafferExecutive officerApr 2016
Joanne H. QuanExecutive officerApr 2016
Krisztina ZseboExecutive officerOct 2013
Rebecque LabaExecutive officerOct 2013
Charles J. BramlageDirectorApr 2016
David A. CoryDirectorApr 2016
Edgar G. EnglemanDirectorApr 2016
Jeffrey S. GlennDirectorApr 2016
Nina S. KjellsonDirectorApr 2016
Thomas J. DietzDirectorApr 2016
Andrew E. SenyeiDirectorOct 2013
Barbara E. DaltonDirectorOct 2013
Daniel E. OmsteadDirectorOct 2013
Fouad E. AzzamDirectorOct 2013
Graham E. CooperDirectorOct 2013
Gregg E. AltonDirectorOct 2013
Johan E. KordelDirectorOct 2013
Joshua E. FunderDirectorOct 2013
Krisztina ZseboDirectorOct 2013
Lauren E. SilvermanDirectorOct 2013
Michael E. NarachiDirectorOct 2013
Todd E. FoleyDirectorOct 2013
Anthony B. EvninDirectorDec 2009
Asish R. XavierDirectorDec 2009
Kenneth R. ChienDirectorDec 2009
Asish XavierDirectorSep 2009